Max Healthcare Institute Limited (NSE:MAXHEALTH)

Max Healthcare Institute Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	87,121	83,735	70,285	54,060	45,626	39,366
Revenue Growth	15.96%	19.14%	30.01%	18.49%	15.90%	56.96%
Gross Profit Gross Profit Growth	54,467	52,263	43,774	33,531	28,312	21,885
Operating Income Operating Income Growth	18,470	17,990	15,275	12,753	10,240	7,580
Net Income Net Income Growth	14,569	14,424	10,759	10,576	11,035	6,051
Earnings Per Share EPS Growth	14.91	14.76	11.01	10.84	11.36	6.24
EPS Growth	27.01%	34.06%	1.57%	-4.58%	82.05%	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	6,658	6,658	6,616	9,798	13,743	4,810
Total Debt Total Debt Growth	34,784	34,784	30,103	12,990	6,890	9,134
Net Cash (Debt) Net Cash Growth	-28,126	-28,126	-23,487	-3,191	6,854	-4,324
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-28.78	-28.78	-24.03	-3.27	7.05	-4.46

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	16,333	14,380	11,217	12,841	7,405
Capital Expenditures CapEx Growth	-	-14,845	-9,445	-7,860	-3,356	-5,533
Free Cash Flow Free Cash Flow Growth	-	1,488	4,935	3,357	9,485	1,872
Free Cash Flow Growth	-	-69.85%	46.99%	-64.61%	406.74%	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	62.52%	62.41%	62.28%	62.02%	62.05%	55.59%
Operating Margin	21.20%	21.48%	21.73%	23.59%	22.44%	19.25%
Pretax Margin	19.64%	20.01%	20.01%	25.26%	23.31%	18.77%
Profit Margin	16.72%	17.23%	15.31%	19.56%	24.19%	15.37%
FCF Margin	-	1.78%	7.02%	6.21%	20.79%	4.75%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Sep 1, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Dividend Per Share Dividend Per Share Growth	2.000	2.000	1.500	1.500	1.000
Dividend Per Share Growth	33.33%	33.33%	0%	50.00%	-
Dividend Yield	0.20%	0.21%	0.14%	0.18%	0.23%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 1, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	68.07	64.88	99.10	75.39	38.80	55.59
P/FCF Ratio	666.55	628.95	216.05	237.51	45.14	179.70
PS Ratio	11.38	11.18	15.17	14.75	9.38	8.55

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 30, 2026

Data Sources Report a data error